Cardiac defibrillation therapy for at risk patients with systemic right ventricular dysfunction secondary to atrial redirection surgery for dextro-transposition of the great arteries
Open Access
- 23 March 2007
- journal article
- case report
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 9 (5) , 281-284
Abstract
To review techniques of implantable cardioverter-defibrillators (ICD) in patients after Mustard surgery for arterial transposition. Retrospective analysis of all Mustard patients receiving ICDs at our institution. Five patients (median age 24 years, range 19–35, 3 male) with systemic right ventricular dysfunction (sRV) dysfunction and New York Heart Association (NYHA) II and III, received ICDs. Implantation was performed transvenously in three patients, epicardial patches and subcutaneous arrays at surgery in two patients. Two patients required lead extraction and baffle stent angioplasty before ICD implantation. Defibrillation vectors incorporating the anterior sRV mass [i.e., sub-pulmonary left ventricle (pLV) to generator can, and between epicardial defibrillator patches], consistently achieved a minimum 10 joule(J) safety margin during defibrillation threshold (DFT) testing. Subcutaneous arrays and endocardial vectors that included a superior vena cava (SVC) electrode were less effective. One patient developed pulmonary oedema post-procedure. At a median 20 months, all patients were alive and in NYHA class II. Follow-up over 24 months documented multiple non-sustained ventricular tachycardia (VT) in the group and one patient had recurrent VT with aborted device therapy. Defibrillator implantation in Mustard patients is challenging. Sub-optimal defibrillation should be anticipated and can be overcome using vectors which integrate the RV mass and high-energy devices. A staged procedure involving pre-implant interventions or separate DFT tests, where indicated, may be better tolerated by patients.Keywords
This publication has 14 references indexed in Scilit:
- Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathyHeart Rhythm, 2005
- Comparison of Ventricular Arrhythmia Frequency in Patients With Ischemic Cardiomyopathy Versus Nonischemic Cardiomyopathy Treated With Implantable Cardioverter DefibrillatorsThe American Journal of Cardiology, 2005
- Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: A long-term follow-upHeart Rhythm, 2005
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Long-term results of left ventricular reconditioning and anatomic correction for systemic right ventricular dysfunction after atrial switch proceduresThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular CardiomyopathyCirculation, 2004
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Polarity Reversal Improves Defibrillation Efficacy in Patients Undergoing Transvenous Cardioverter Defibrillator Implantation with Biphasic SbocksPacing and Clinical Electrophysiology, 1997
- Optimal electrode position for transvenous defibrillation: A prospective randomized studyJACC, 1996
- Transseptal Defibrillation Is Superior for Transvenous DefibrillationPacing and Clinical Electrophysiology, 1995